This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid009I
It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid009I.html
Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine.
The full table of all monthly collections is: at house-of-papers.com
PMC searches were done at moremed.org





{{tp|p=32535228|t=2020. Structural analysis of the putative SARS-CoV-2 primase complex.|pdf=|usr=}}
{{tp|p=32398026|t=2020. Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.|pdf=|usr=}}
{{tp|p=32522207|t=2020. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32487093|t=2020. The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.|pdf=|usr=}}
{{tp|p=31712093|t=2020. Rapid manipulation of the porcine epidemic diarrhea virus genome by CRISPR/Cas9 technology.|pdf=|usr=}}
{{tp|p=32405428|t=2020. Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections, 8-11 March 2020, Boston, USA.|pdf=|usr=}}
{{tp|p=32437497|t=2020. Postmortem Examination of Patients With COVID-19.|pdf=|usr=}}
{{tp|p=32412415|t=2020. A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis.|pdf=|usr=}}
{{tp|p=32461141|t=2020. The case of Complement activation in COVID-19 multiorgan impact.|pdf=|usr=}}
{{tp|p=32446936|t=2020. Electron Microscopic Investigations in COVID-19: Not all Crowns Are Coronas.|pdf=|usr=}}
{{tp|p=32525010|t=2020. Thrombotic microangiopathy in a patient with COVID-19.|pdf=|usr=}}
{{tp|p=32437766|t=2020. Multivesicular bodies mimicking SARS-CoV-2 in patients without COVID-19.|pdf=|usr=}}
{{tp|p=32437765|t=2020. Autophagy inhibition by chloroquine and hydroxychloroquine could adversely affect acute kidney injury and other organ injury in critically ill patients with COVID-19.|pdf=|usr=}}
{{tp|p=32426558|t=2020. Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against "SARS-CoV-2 nephropathy".|pdf=|usr=}}
{{tp|p=32442529|t=2020. Electron microscopy of SARS-CoV-2: a challenging task.|pdf=|usr=}}
{{tp|p=32442527|t=2020. Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.|pdf=|usr=}}
{{tp|p=32464112|t=2020. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?|pdf=|usr=}}
{{tp|p=32446324|t=2020. Detection of SARS-CoV-2 in human breastmilk.|pdf=|usr=}}
{{tp|p=32482418|t=2020. Research during SARS-CoV-2 pandemic: To "Preprint" or not to "Preprint", that is the question.|pdf=|usr=}}
{{tp|p=32395713|t=2020. Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis.|pdf=|usr=}}
{{tp|p=32504925|t=2020. What would Sergio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?|pdf=|usr=}}
{{tp|p=32464496|t=2020. Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19.|pdf=|usr=}}
{{tp|p=32505066|t=2020. COVID-19: Loss of bridging between innate and adaptive immunity?|pdf=|usr=}}
{{tp|p=32460210|t=2020. "Therapeutic" facemasks.|pdf=|usr=}}
{{tp|p=32425304|t=2020. Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?|pdf=|usr=}}
{{tp|p=32447232|t=2020. COVID-19: beta-thalassemia subjects immunised?|pdf=|usr=}}
{{tp|p=32534341|t=2020. Could the decrease in the endothelial nitric oxide (NO) production and NO bioavailability be the crucial cause of COVID-19 related deaths?|pdf=|usr=}}
{{tp|p=32534340|t=2020. The intriguing commonality of NETosis between COVID-19 & Periodontal disease.|pdf=|usr=}}
{{tp|p=32534339|t=2020. A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?|pdf=|usr=}}
{{tp|p=32505073|t=2020. Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression.|pdf=|usr=}}
{{tp|p=32445664|t=2020. COVID-19 as a cause of immune thrombocytopenia.|pdf=|usr=}}
{{tp|p=32391393|t=2020. Digesting the crisis: autophagy and coronaviruses.|pdf=|usr=}}
{{tp|p=32405236|t=2020. Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.|pdf=|usr=}}
{{tp|p=32446902|t=2020. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.|pdf=|usr=}}
{{tp|p=32425647|t=2020. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency.|pdf=|usr=}}
{{tp|p=32381617|t=2020. Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru.|pdf=|usr=}}
{{tp|p=32467284|t=2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt.|pdf=|usr=}}
{{tp|p=32467283|t=2020. Complete Genome Sequence of SARS-CoV-2 in a Tiger from a U.S. Zoological Collection.|pdf=|usr=}}
{{tp|p=32409547|t=2020. Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia.|pdf=|usr=}}
{{tp|p=32527780|t=2020. Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from Bangladesh.|pdf=|usr=}}
{{tp|p=32501301|t=2020. A rapid screening method for testing the efficiency of masks in breaking down aerosols.|pdf=|usr=}}
{{tp|p=32531352|t=2020. Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019 - COVID-19.|pdf=|usr=}}
{{tp|p=32393381|t=2020. Perceived infection transmission routes, infection control practices, psychosocial changes, and management of COVID-19 infected healthcare workers in a tertiary acute care hospital in Wuhan: a cross-sectional survey.|pdf=|usr=}}
{{tp|p=32518047|t=2020. Cadaverless anatomy: Darkness in the times of pandemic Covid-19.|pdf=|usr=}}
{{tp|p=32427981|t=2020. Organoids demonstrate gut infection by SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32461674|t=2020. The non-specific and sex-differential effects of vaccines.|pdf=|usr=}}
{{tp|p=32461672|t=2020. Kawasaki disease linked to COVID-19 in children.|pdf=|usr=}}
{{tp|p=32461671|t=2020. Innate T cells in COVID-19: friend or foe?|pdf=|usr=}}
{{tp|p=32457522|t=2020. Dysregulation of type I interferon responses in COVID-19.|pdf=|usr=}}
{{tp|p=32439870|t=2020. COVID-19: the vasculature unleashed.|pdf=|usr=}}
{{tp|p=32409742|t=2020. SARS-CoV-2 likes it cool.|pdf=|usr=}}
{{tp|p=32409741|t=2020. Modulation of immune crosstalk in COVID-19.|pdf=|usr=}}
{{tp|p=32514035|t=2020. Dissecting antibody-mediated protection against SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32504061|t=2020. SARS-CoV-2 cross-reactivity in healthy donors.|pdf=|usr=}}
{{tp|p=32504060|t=2020. Immune evasion via SARS-CoV-2 ORF8 protein?|pdf=|usr=}}
{{tp|p=32504059|t=2020. Many paths to COVID-19 lymphocyte dysfunction.|pdf=|usr=}}
{{tp|p=32488201|t=2020. Blood clots and TAM receptor signalling in COVID-19 pathogenesis.|pdf=|usr=}}
{{tp|p=32533111|t=2020. A versatile mouse model of COVID-19.|pdf=|usr=}}
{{tp|p=32533110|t=2020. SARS-CoV-2 has a sweet tooth.|pdf=|usr=}}
{{tp|p=32528136|t=2020. Considering how biological sex impacts immune responses and COVID-19 outcomes.|pdf=|usr=}}
{{tp|p=32415242|t=2020. A spike with which to beat COVID-19?|pdf=|usr=}}
{{tp|p=32488173|t=2020. Antimicrobial use, drug-resistant infections and COVID-19.|pdf=|usr=}}
{{tp|p=32528128|t=2020. Bat-borne virus diversity, spillover and emergence.|pdf=|usr=}}
{{tp|p=32483314|t=2020. COVID-19: organoids go viral.|pdf=|usr=}}
{{tp|p=32445105|t=2020. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.|pdf=|usr=}}
{{tp|p=32509310|t=2020. Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations.|pdf=|usr=}}
{{tp|p=32483490|t=2020. The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19.|pdf=|usr=}}
{{tp|p=32292587|t=2020. Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future.|pdf=|usr=}}
{{tp|p=32427206|t=2020. Rare and extreme events: the case of COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32425360|t=2020. Systemic endothelial dysfunction: a common pathway for COVID-19, cardiovascular and metabolic diseases.|pdf=|usr=}}
{{tp|p=32409839|t=2020. Physician deaths from corona virus (COVID-19) disease.|pdf=|usr=}}
{{tp|p=32532805|t=2020. Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase.|pdf=|usr=}}
{{tp|p=32519118|t=2020. Okulare Post-mortem-Befunde bei an COVID-19 verstorbenen Patienten.|pdf=|usr=}}
{{tp|p=32412525|t=2020. The Myriad Ways in Which COVID-19 Revealed Character.|pdf=|usr=}}
{{tp|p=32528816|t=2020. Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea.|pdf=|usr=}}
{{tp|p=32528815|t=2020. Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome.|pdf=|usr=}}
{{tp|p=32397138|t=2020. A Systematic Review Analyzing the Prevalence and Circulation of Influenza Viruses in Swine Population Worldwide.|pdf=|usr=}}
{{tp|p=32529358|t=2020. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital.|pdf=|usr=}}
{{tp|p=32509472|t=2020. Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions.|pdf=|usr=}}
{{tp|p=32464327|t=2020. COVID-19 and Kawasaki disease in children.|pdf=|usr=}}
{{tp|p=32447571|t=2020. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.|pdf=|usr=}}
{{tp|p=32462744|t=2020. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.|pdf=|usr=}}
{{tp|p=32405877|t=2020. A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?|pdf=|usr=}}
{{tp|p=32466999|t=2020. COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?|pdf=|usr=}}
{{tp|p=32515676|t=2020. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series.|pdf=|usr=}}
{{tp|p=32399393|t=2020. The potential role of TNFalpha in 2019 novel coronavirus pneumonia.|pdf=|usr=}}
{{tp|p=32415310|t=2020. Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19).|pdf=|usr=}}
{{tp|p=32533292|t=2020. Targeting the immunology of coronavirus disease-19: synchronization creates symphony.|pdf=|usr=}}
{{tp|p=32445403|t=2020. SARS-CoV-2 infection-induced immune responses: Friends or foes?|pdf=|usr=}}
{{tp|p=32434946|t=2020. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.|pdf=|usr=}}
{{tp|p=32513865|t=2020. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California.|pdf=|usr=}}
{{tp|p=32388537|t=2020. Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro).|pdf=|usr=}}
{{tp|p=32435059|t=2020. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.|pdf=|usr=}}
{{tp|p=32532959|t=2020. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.|pdf=|usr=}}
{{tp|p=32399806|t=2020. Is COVID-19 a New Hematologic Disease?|pdf=|usr=}}
{{tp|p=32500482|t=2020. Induced Pluripotent Stem Cells (iPSCs) Derived 3D Human Lung Organoids from Different Ethnicities to Understand the SARS-CoV2 Severity/Infectivity Percentage.|pdf=|usr=}}
{{tp|p=32528206|t=2020. COVID-19 and lessons learned from the pandemic wave of meningococcal meningitis (1985-1990).|pdf=|usr=}}
{{tp|p=32528193|t=2020. The Sudanese/British doctors who offered their lives fighting coronavirus (COVID-19) pandemic.|pdf=|usr=}}
{{tp|p=32505009|t=2020. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients.|pdf=|usr=}}
{{tp|p=32387238|t=2020. Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?|pdf=|usr=}}
{{tp|p=32473312|t=2020. Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis.|pdf=|usr=}}
{{tp|p=32317245|t=2020. Ger Rijkers: Persistence of Memory in Times of COVID-19.|pdf=|usr=}}
{{tp|p=32423553|t=2020. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32500504|t=2020. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.|pdf=|usr=}}
{{tp|p=32434416|t=2020. Mice with humanized-lungs and immune system - an idealized model for COVID-19 and other respiratory illness.|pdf=|usr=}}
{{tp|p=32431949|t=2020. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses.|pdf=|usr=}}
{{tp|p=32531235|t=2020. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.|pdf=|usr=}}
{{tp|p=32430279|t=2020. Gut microbiota and Covid-19- possible link and implications.|pdf=|usr=}}
{{tp|p=32417181|t=2020. COVID-19: CADD to the rescue.|pdf=|usr=}}
{{tp|p=32416259|t=2020. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2.|pdf=|usr=}}
{{tp|p=32517266|t=2020. Propagation, Inactivation, and Safety Testing of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32512929|t=2020. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.|pdf=|usr=}}

PMC7289108 1. Structural analysis of the putative SARS-CoV-2 primase complex.

J Struct Biol 2020; ä (ä): 107548

*32535228*
                       32535228

PMC7215129 2. Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.

J Transl Med 2020; 18 (1): 196

*32398026*
                       32398026

PMC7286221 3. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.

J Transl Med 2020; 18 (1): 233

*32522207*
                       32522207

PMC7266426 4. The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.

J Transl Med 2020; 18 (1): 219

*32487093*
                       32487093

PMC7113866 5. Rapid manipulation of the porcine epidemic diarrhea virus genome by CRISPR/Cas9 technology.

J Virol Methods 2020; 276 (ä): 113772

*31712093*
                       31712093

PMC7213072 6. Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections, 8-11 March 2020, Boston, USA.

J Virus Erad 2020; 6 (2): 96-99

*32405428*
                       32405428

PMC7243161 7. Postmortem Examination of Patients With COVID-19.

JAMA 2020; ä (ä): ä

*32437497*
                       32437497

PMC7265655 8. A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis.

JMIR Public Health Surveill 2020; 6 (2): e19170

*32412415*
                       32412415

PMC7246017 9. The case of Complement activation in COVID-19 multiorgan impact.

Kidney Int 2020; ä (ä): ä

*32461141*
                       32461141

PMC7242192 10. Electron Microscopic Investigations in COVID-19: Not all Crowns Are Coronas.

Kidney Int 2020; ä (ä): ä

*32446936*
                       32446936

PMC7276225 11. Thrombotic microangiopathy in a patient with COVID-19.

Kidney Int 2020; ä (ä): ä

*32525010*
                       32525010

PMC7206432 12. Multivesicular bodies mimicking SARS-CoV-2 in patients without COVID-19.

Kidney Int 2020; 98 (1): 233-234

*32437766*
                       32437766

PMC7207116 13. Autophagy inhibition by chloroquine and hydroxychloroquine could adversely affect acute kidney injury and other organ injury in critically ill patients with COVID-19.

Kidney Int 2020; 98 (1): 234-235

*32437765*
                       32437765

PMC7230145 14. Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against "SARS-CoV-2 nephropathy".

Kidney Int Rep 2020; ä (ä): ä

*32426558*
                       32426558

PMC7237172 15. Electron microscopy of SARS-CoV-2: a challenging task.

Lancet 2020; 395 (10238): e99

*32442529*
                       32442529

PMC7237177 16. Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.

Lancet 2020; 395 (10238): e100

*32442527*
                       32442527

PMC7247793 17. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?

Lancet 2020; 395 (10239): 1758-1759

*32464112*
                       32464112

PMC7241971 18. Detection of SARS-CoV-2 in human breastmilk.

Lancet 2020; 395 (10239): 1757-1758

*32446324*
                       32446324

PMC7205732 19. Research during SARS-CoV-2 pandemic: To "Preprint" or not to "Preprint", that is the question.

Med Clin (Barc) 2020; ä (ä): ä

*32482418*
                       32482418

PMC7211589 20. Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis.

Med Drug Discov 2020; ä (ä): 100044

*32395713*
                       32395713

PMC7261103 21. What would Sergio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?

Med Hypotheses 2020; 143 (ä): 109886

*32504925*
                       32504925

PMC7246007 22. Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19.

Med Hypotheses 2020; 143 (ä): 109877

*32464496*
                       32464496

PMC7245229 23. COVID-19: Loss of bridging between innate and adaptive immunity?

Med Hypotheses 2020; 144 (ä): 109861

*32505066*
                       32505066

PMC7236693 24. "Therapeutic" facemasks.

Med Hypotheses 2020; 143 (ä): 109855

*32460210*
                       32460210

PMC7227545 25. Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?

Med Hypotheses 2020; 143 (ä): 109842

*32425304*
                       32425304

PMC7217120 26. COVID-19: beta-thalassemia subjects immunised?

Med Hypotheses 2020; 142 (ä): 109827

*32447232*
                       32447232

PMC7276137 27. Could the decrease in the endothelial nitric oxide (NO) production and NO bioavailability be the crucial cause of COVID-19 related deaths?

Med Hypotheses 2020; 144 (ä): 109970

*32534341*
                       32534341

PMC7276117 28. The intriguing commonality of NETosis between COVID-19 & Periodontal disease.

Med Hypotheses 2020; 144 (ä): 109968

*32534340*
                       32534340

PMC7274980 29. A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?

Med Hypotheses 2020; 144 (ä): 109959

*32534339*
                       32534339

PMC7263251 30. Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression.

Med Hypotheses 2020; 144 (ä): 109936

*32505073*
                       32505073

PMC7239020 31. COVID-19 as a cause of immune thrombocytopenia.

Med Mal Infect 2020; ä (ä): ä

*32445664*
                       32445664

PMC7199282 32. Digesting the crisis: autophagy and coronaviruses.

Microb Cell 2020; 7 (5): 119-128

*32391393*
                       32391393

PMC7217786 33. Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.

Microbes Infect 2020; ä (ä): ä

*32405236*
                       32405236

PMC7241347 34. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.

Microbes Infect 2020; 22 (4-5): 182-187

*32446902*
                       32446902

PMC7229726 35. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency.

Microbes Infect 2020; 22 (4-5): 149-150

*32425647*
                       32425647

PMC7206495 36. Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru.

Microbiol Resour Announc 2020; 9 (19): ä

*32381617*
                       32381617

PMC7256271 37. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt.

Microbiol Resour Announc 2020; 9 (22): ä

*32467284*
                       32467284

PMC7256270 38. Complete Genome Sequence of SARS-CoV-2 in a Tiger from a U.S. Zoological Collection.

Microbiol Resour Announc 2020; 9 (22): ä

*32467283*
                       32467283

PMC7225546 39. Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia.

Microbiol Resour Announc 2020; 9 (20): ä

*32409547*
                       32409547

40. Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from Bangladesh.

Microbiol Resour Announc 2020; 9 (24): ä

*32527780*
                       32527780

PMC7252045 41. A rapid screening method for testing the efficiency of masks in breaking down aerosols.

Microchem J 2020; 157 (ä): 104928

*32501301*
                       32501301

PMC7280818 42. Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019 - COVID-19.

Microvasc Res 2020; 131 (ä): 104028

*32531352*
                       32531352

PMC7211983 43. Perceived infection transmission routes, infection control practices, psychosocial changes, and management of COVID-19 infected healthcare workers in a tertiary acute care hospital in Wuhan: a cross-sectional survey.

Mil Med Res 2020; 7 (1): 24

*32393381*
                       32393381

PMC7254017 44. Cadaverless anatomy: Darkness in the times of pandemic Covid-19.

Morphologie 2020; ä (ä): ä

*32518047*
                       32518047

PMC7235550 45. Organoids demonstrate gut infection by SARS-CoV-2.

Nat Rev Gastroenterol Hepatol 2020; 17 (7): 383

*32427981*
                       32427981

PMC7252419 46. The non-specific and sex-differential effects of vaccines.

Nat Rev Immunol 2020; ä (ä): ä

*32461674*
                       32461674

PMC7251555 47. Kawasaki disease linked to COVID-19 in children.

Nat Rev Immunol 2020; 20 (7): 407

*32461672*
                       32461672

PMC7251553 48. Innate T cells in COVID-19: friend or foe?

Nat Rev Immunol 2020; 20 (7): 407

*32461671*
                       32461671

PMC7249038 49. Dysregulation of type I interferon responses in COVID-19.

Nat Rev Immunol 2020; 20 (7): 397-398

*32457522*
                       32457522

PMC7240244 50. COVID-19: the vasculature unleashed.

Nat Rev Immunol 2020; 20 (7): 389-391

*32439870*
                       32439870

PMC7224124 51. SARS-CoV-2 likes it cool.

Nat Rev Immunol 2020; 20 (7): 406

*32409742*
                       32409742

PMC7224130 52. Modulation of immune crosstalk in COVID-19.

Nat Rev Immunol 2020; 20 (7): 406

*32409741*
                       32409741

PMC7278217 53. Dissecting antibody-mediated protection against SARS-CoV-2.

Nat Rev Immunol 2020; 20 (7): 392-394

*32514035*
                       32514035

PMC7274045 54. SARS-CoV-2 cross-reactivity in healthy donors.

Nat Rev Immunol 2020; 20 (7): 408

*32504061*
                       32504061

PMC7273379 55. Immune evasion via SARS-CoV-2 ORF8 protein?

Nat Rev Immunol 2020; 20 (7): 408

*32504060*
                       32504060

PMC7273380 56. Many paths to COVID-19 lymphocyte dysfunction.

Nat Rev Immunol 2020; 20 (7): 408

*32504059*
                       32504059

PMC7264968 57. Blood clots and TAM receptor signalling in COVID-19 pathogenesis.

Nat Rev Immunol 2020; 20 (7): 395-396

*32488201*
                       32488201

PMC7291937 58. A versatile mouse model of COVID-19.

Nat Rev Immunol 2020; ä (ä): ä

*32533111*
                       32533111

PMC7291939 59. SARS-CoV-2 has a sweet tooth.

Nat Rev Immunol 2020; ä (ä): ä

*32533110*
                       32533110

PMC7288618 60. Considering how biological sex impacts immune responses and COVID-19 outcomes.

Nat Rev Immunol 2020; 20 (7): 442-447

*32528136*
                       32528136

PMC7225630 61. A spike with which to beat COVID-19?

Nat Rev Microbiol 2020; ä (ä): ä

*32415242*
                       32415242

PMC7264971 62. Antimicrobial use, drug-resistant infections and COVID-19.

Nat Rev Microbiol 2020; ä (ä): ä

*32488173*
                       32488173

PMC7289071 63. Bat-borne virus diversity, spillover and emergence.

Nat Rev Microbiol 2020; ä (ä): ä

*32528128*
                       32528128

PMC7262486 64. COVID-19: organoids go viral.

Nat Rev Mol Cell Biol 2020; 21 (7): 355-356

*32483314*
                       32483314

PMC7243953 65. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.

Neurocrit Care 2020; ä (ä): ä

*32445105*
                       32445105

PMC7238997 66. Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations.

New Microbes New Infect 2020; 36 (ä): 100696

*32509310*
                       32509310

PMC7234940 67. The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19.

New Microbes New Infect 2020; 36 (ä): 100697

*32483490*
                       32483490

PMC7129032 68. Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future.

New Microbes New Infect 2020; ä (ä): 100673

*32292587*
                       32292587

PMC7229440 69. Rare and extreme events: the case of COVID-19 pandemic.

Nonlinear Dyn 2020; ä (ä): 1-20

*32427206*
                       32427206

PMC7233254 70. Systemic endothelial dysfunction: a common pathway for COVID-19, cardiovascular and metabolic diseases.

Nutr Metab Cardiovasc Dis 2020; ä (ä): ä

*32425360*
                       32425360

PMC7239175 71. Physician deaths from corona virus (COVID-19) disease.

Occup Med (Lond) 2020; ä (ä): ä

*32409839*
                       32409839

PMC7298678 72. Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase.

Open Heart 2020; 7 (1): ä

*32532805*
                       32532805

PMC7282200 73. Okulare Post-mortem-Befunde bei an COVID-19 verstorbenen Patienten.

Ophthalmologe 2020; ä (ä): ä

*32519118*
                       32519118

PMC7221376 74. The Myriad Ways in Which COVID-19 Revealed Character.

Organ Dyn 2020; ä (ä): 100765

*32412525*
                       32412525

PMC7282421 75. Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea.

Osong Public Health Res Perspect 2020; 11 (3): 112-117

*32528816*
                       32528816

PMC7282418 76. Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome.

Osong Public Health Res Perspect 2020; 11 (3): 101-111

*32528815*
                       32528815

PMC7281378 77. A Systematic Review Analyzing the Prevalence and Circulation of Influenza Viruses in Swine Population Worldwide.

Pathogens 2020; 9 (5): ä

*32397138*
                       32397138

PMC7289638 78. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital.

Pediatr Cardiol 2020; ä (ä): ä

*32529358*
                       32529358

PMC7246029 79. Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions.

PeerJ 2020; 8 (ä): e9255

*32509472*
                       32509472

PMC7247462 80. COVID-19 and Kawasaki disease in children.

Pharmacol Res 2020; 159 (ä): 104951

*32464327*
                       32464327

PMC7245191 81. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.

Protein J 2020; 39 (3): 198-216

*32447571*
                       32447571

PMC7267140 82. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.

Proteomics 2020; ä (ä): e2000107

*32462744*
                       32462744

PMC7218701 83. A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?

Pulm Ther 2020; ä (ä): ä

*32405877*
                       32405877

PMC7236731 84. COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?

Pulmonology 2020; ä (ä): ä

*32466999*
                       32466999

PMC7294821 85. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series.

Radiology 2020; ä (ä): 202288

*32515676*
                       32515676

PMC7215148 86. The potential role of TNFalpha in 2019 novel coronavirus pneumonia.

Respir Med Case Rep 2020; ä (ä): 101087

*32399393*
                       32399393

PMC7227450 87. Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19).

Rheumatol Int 2020; 40 (7): 1177-1179

*32415310*
                       32415310

PMC7290150 88. Targeting the immunology of coronavirus disease-19: synchronization creates symphony.

Rheumatol Int 2020; 40 (8): 1343-1345

*32533292*
                       32533292

PMC7267129 89. SARS-CoV-2 infection-induced immune responses: Friends or foes?

Scand J Immunol 2020; ä (ä): e12895

*32445403*
                       32445403

PMC7243369 90. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.

Science 2020; ä (ä): ä

*32434946*
                       32434946

PMC7286545 91. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California.

Science 2020; ä (ä): ä

*32513865*
                       32513865

PMC7210460 92. Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro).

Signal Transduct Target Ther 2020; 5 (1): 67

*32388537*
                       32388537

PMC7239689 93. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.

Signal Transduct Target Ther 2020; 5 (1): 71

*32435059*
                       32435059

PMC7289711 94. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.

Signal Transduct Target Ther 2020; 5 (1): 92

*32532959*
                       32532959

PMC7217340 95. Is COVID-19 a New Hematologic Disease?

Stem Cell Rev Rep 2020; ä (ä): ä

*32399806*
                       32399806

PMC7272136 96. Induced Pluripotent Stem Cells (iPSCs) Derived 3D Human Lung Organoids from Different Ethnicities to Understand the SARS-CoV2 Severity/Infectivity Percentage.

Stem Cell Rev Rep 2020; ä (ä): ä

*32500482*
                       32500482

PMC7282429 97. COVID-19 and lessons learned from the pandemic wave of meningococcal meningitis (1985-1990).

Sudan J Paediatr 2020; 20 (1): 77-88

*32528206*
                       32528206

PMC7282427 98. The Sudanese/British doctors who offered their lives fighting coronavirus (COVID-19) pandemic.

Sudan J Paediatr 2020; 20 (1): 2-3

*32528193*
                       32528193

PMC7245313 99. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients.

Thromb Res 2020; 192 (ä): 174-175

*32505009*
                       32505009

PMC7252011 100. Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?

Transfus Apher Sci 2020; 59 (3): 102804

*32387238*
                       32387238

PMC7253999 101. Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis.

Travel Med Infect Dis 2020; ä (ä): 101751

*32473312*
                       32473312

PMC7151267 102. Ger Rijkers: Persistence of Memory in Times of COVID-19.

Trends Immunol 2020; 41 (6): 453

*32317245*
                       32317245

PMC7211701 103. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.

Vascul Pharmacol 2020; 130 (ä): 106680

*32423553*
                       32423553

PMC7271831 104. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.

Virol Sin 2020; ä (ä): ä

*32500504*
                       32500504

PMC7250318 105. Mice with humanized-lungs and immune system - an idealized model for COVID-19 and other respiratory illness.

Virulence 2020; 11 (1): 486-488

*32434416*
                       32434416

PMC7223271 106. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses.

Virus Evol 2020; 6 (1): veaa032

*32431949*
                       32431949

PMC7282740 107. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.

Virus Res 2020; 286 (ä): 198058

*32531235*
                       32531235

PMC7217790 108. Gut microbiota and Covid-19- possible link and implications.

Virus Res 2020; 285 (ä): 198018

*32430279*
                       32430279

PMC7228740 109. COVID-19: CADD to the rescue.

Virus Res 2020; 285 (ä): 198022

*32417181*
                       32417181

PMC7228703 110. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2.

Virus Res 2020; 285 (ä): 198021

*32416259*
                       32416259

111. Propagation, Inactivation, and Safety Testing of SARS-CoV-2.

Viruses 2020; 12 (6): ä

*32517266*
                       32517266

112. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.

Viruses 2020; 12 (6): ä

*32512929*
                       32512929


{{tp|p=32410760|t=2020. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.|pdf=|usr=}}
{{tp|p=32410759|t=2020. Kawasaki-like disease: emerging complication during the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32534627|t=2020. Have deaths from COVID-19 in Europe plateaued due to herd immunity?|pdf=|usr=}}
{{tp|p=32534626|t=2020. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.|pdf=|usr=}}
{{tp|p=32246939|t=2020. SARS-CoV-2 in wastewater: potential health risk, but also data source.|pdf=|usr=}}
{{tp|p=32220289|t=2020. Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility.|pdf=|usr=}}
{{tp|p=32386610|t=2020. Prevention of the cytokine storm in COVID-19.|pdf=|usr=}}
{{tp|p=32526193|t=2020. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.|pdf=|usr=}}
{{tp|p=32526191|t=2020. Pathologists in pursuit of the COVID-19 culprit.|pdf=|usr=}}
{{tp|p=32470417|t=2020. COVID-19 international neurological registries.|pdf=|usr=}}
{{tp|p=32386571|t=2020. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.|pdf=|usr=}}
{{tp|p=32386570|t=2020. Assessment of SARS-CoV-2 replication in the context of other respiratory viruses.|pdf=|usr=}}
{{tp|p=32473124|t=2020. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.|pdf=|usr=}}
{{tp|p=32473123|t=2020. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission.|pdf=|usr=}}
{{tp|p=32446313|t=2020. Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32422178|t=2020. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.|pdf=|usr=}}
{{tp|p=32422177|t=2020. Pulmonary fibrosis secondary to COVID-19: a call to arms?|pdf=|usr=}}
{{tp|p=32427161|t=2020. Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms.|pdf=|usr=}}
{{tp|p=32483300|t=2020. SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells.|pdf=|usr=}}
{{tp|p=32502542|t=2020. The immune system and COVID-19: Friend or foe?|pdf=|usr=}}
{{tp|p=32430402|t=2020. Could severe COVID-19 be considered a complementopathy?|pdf=|usr=}}
{{tp|p=32284797|t=2020. We have to write and share valid and reliable information on COVID-19.|pdf=|usr=}}

PMC7220177 113. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.

Lancet 2020; 395 (10239): 1771-1778

*32410760*
                       32410760

PMC7220168 114. Kawasaki-like disease: emerging complication during the COVID-19 pandemic.

Lancet 2020; 395 (10239): 1741-1743

*32410759*
                       32410759

PMC7289569 115. Have deaths from COVID-19 in Europe plateaued due to herd immunity?

Lancet 2020; 395 (10241): e110-e111

*32534627*
                       32534627

PMC7289564 116. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.

Lancet 2020; ä (ä): ä

*32534626*
                       32534626

PMC7225404 117. SARS-CoV-2 in wastewater: potential health risk, but also data source.

Lancet Gastroenterol Hepatol 2020; 5 (6): 533-534

*32246939*
                       32246939

PMC7159059 118. Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility.

Lancet Glob Health 2020; 8 (5): e627-e630

*32220289*
                       32220289

PMC7252095 119. Prevention of the cytokine storm in COVID-19.

Lancet Infect Dis 2020; ä (ä): ä

*32386610*
                       32386610

PMC7279758 120. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.

Lancet Infect Dis 2020; ä (ä): ä

*32526193*
                       32526193

PMC7279719 121. Pathologists in pursuit of the COVID-19 culprit.

Lancet Infect Dis 2020; ä (ä): ä

*32526191*
                       32526191

PMC7250559 122. COVID-19 international neurological registries.

Lancet Neurol 2020; 19 (6): 484-485

*32470417*
                       32470417

PMC7252187 123. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.

Lancet Respir Med 2020; ä (ä): ä

*32386571*
                       32386571

PMC7252006 124. Assessment of SARS-CoV-2 replication in the context of other respiratory viruses.

Lancet Respir Med 2020; ä (ä): ä

*32386570*
                       32386570

PMC7255143 125. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.

Lancet Respir Med 2020; ä (ä): ä

*32473124*
                       32473124

PMC7255254 126. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission.

Lancet Respir Med 2020; ä (ä): ä

*32473123*
                       32473123

PMC7241998 127. Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2.

Lancet Respir Med 2020; ä (ä): ä

*32446313*
                       32446313

PMC7228727 128. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.

Lancet Respir Med 2020; ä (ä): ä

*32422178*
                       32422178

PMC7228737 129. Pulmonary fibrosis secondary to COVID-19: a call to arms?

Lancet Respir Med 2020; ä (ä): ä

*32422177*
                       32422177

PMC7228732 130. Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms.

Lancet Rheumatol 2020; ä (ä): ä

*32427161*
                       32427161

PMC7262681 131. SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells.

Leukemia 2020; ä (ä): ä

*32483300*
                       32483300

PMC7266583 132. The immune system and COVID-19: Friend or foe?

Life Sci 2020; 256 (ä): 117900

*32502542*
                       32502542

PMC7246101 133. Could severe COVID-19 be considered a complementopathy?

Lupus Sci Med 2020; 7 (1): ä

*32430402*
                       32430402

PMC7136682 134. We have to write and share valid and reliable information on COVID-19.

Malays Fam Physician 2020; 15 (1): 1

*32284797*
                       32284797